- UID
- 1378351
- 在线时间
- 小时
- 注册时间
- 2018-12-16
- 最后登录
- 1970-1-1
- 主题
- 帖子
- 性别
- 保密
|
曼哈顿题源
A certain pharmaceutical firm recently developed a new medicine, Dendadrine, that provides highly effective treatment of severe stomach disorders that were previously thought to be incurable. However, to develop the new medicine, the company spent nearly $5 billion in research and development costs. Given the size of the market for Dendadrine and the amount of the initial investment in its development, the company would need to sell Dendadrine at a price that is at least 5 times greater than its variable costs just to break even. Yet the company’s management claims that Dendadrine will soon become the major driver of the firm’s profits.
Which of the following statements best reconciles the management’s claim with the evidence on the expenditures associated with the development of Dendadrine?
文章大意应该就是要我们选一个证明新药确实能offset成本的描述,换句话说就是选一个说能产生更多profit的选项,但是我做的时候直接就用“客户量”这个指标(或者回答“没人买呢? or 患者少了呢?”【yes/no】)来衡量每个选项的全面性,发现全都不行,然后就迷茫了,到底应该如何来判断~~求大神解答~~~~谢谢!!!
|
|